News

Researchers have uncovered a crucial enzyme responsible for a specific chemical modification linked to the growth of a severe subtype of acute myeloid leukemia…

CagriSema significantly reduced body weight and HbA1c in adults with Type 2 diabetes in new Phase 3 trial.

The biomarker identifies those at highest risk of non-adherence and helps determine how much support they receive during the intervention.

Preliminary outcomes indicated that AE may improve haemoglobin levels, possibly counteracting androgen deprivation therapy induced reductions.

A new study highlights the pressing need for transparent communication and tailored education for patients managing both rheumatoid arthritis and cancer.

Early trial data show that olorofim may offer a valuable new option for patients with resistant invasive fungal infections.

New research at ESHRE 2025 shows a cfRNA blood test can predict preeclampsia up to five months before symptoms appear.

Although GLP-1 medicines are generally well tolerated, there have been reports of rare but serious cases of acute pancreatitis.